JP2024540439A5 - - Google Patents

Info

Publication number
JP2024540439A5
JP2024540439A5 JP2024527790A JP2024527790A JP2024540439A5 JP 2024540439 A5 JP2024540439 A5 JP 2024540439A5 JP 2024527790 A JP2024527790 A JP 2024527790A JP 2024527790 A JP2024527790 A JP 2024527790A JP 2024540439 A5 JP2024540439 A5 JP 2024540439A5
Authority
JP
Japan
Prior art keywords
composition
use according
nitroxoline
dose
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024527790A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540439A (ja
Filing date
Publication date
Priority claimed from GBGB2116743.2A external-priority patent/GB202116743D0/en
Application filed filed Critical
Publication of JP2024540439A publication Critical patent/JP2024540439A/ja
Publication of JP2024540439A5 publication Critical patent/JP2024540439A5/ja
Pending legal-status Critical Current

Links

JP2024527790A 2021-11-19 2022-11-18 叢状神経線維腫の治療又は予防に使用するためのニトロキソリン Pending JP2024540439A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2116743.2A GB202116743D0 (en) 2021-11-19 2021-11-19 Treatment
GB2116743.2 2021-11-19
PCT/GB2022/052933 WO2023089328A1 (en) 2021-11-19 2022-11-18 Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma

Publications (2)

Publication Number Publication Date
JP2024540439A JP2024540439A (ja) 2024-10-31
JP2024540439A5 true JP2024540439A5 (enExample) 2025-11-17

Family

ID=79163954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527790A Pending JP2024540439A (ja) 2021-11-19 2022-11-18 叢状神経線維腫の治療又は予防に使用するためのニトロキソリン

Country Status (11)

Country Link
US (1) US20250000852A1 (enExample)
EP (1) EP4433054B1 (enExample)
JP (1) JP2024540439A (enExample)
KR (1) KR20240108407A (enExample)
CN (1) CN118215479A (enExample)
AU (1) AU2022392456A1 (enExample)
CA (1) CA3238805A1 (enExample)
GB (1) GB202116743D0 (enExample)
IL (1) IL312885A (enExample)
MX (1) MX2024006105A (enExample)
WO (1) WO2023089328A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202218460D0 (en) * 2022-12-08 2023-01-25 Healx Ltd Treatment
WO2026022492A1 (en) * 2024-07-26 2026-01-29 Healx Limited Nitroxoline for use in the treatment and/or prevention of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102239149B (zh) * 2008-10-06 2015-05-13 约翰·霍普金斯大学 喹啉化合物作为血管新生、人类甲硫氨酰氨肽酶、以及sirt1的抑制剂,以及治疗病症的方法
GB202108224D0 (en) * 2021-06-09 2021-07-21 Healx Ltd Treatment

Similar Documents

Publication Publication Date Title
JP2023041862A5 (enExample)
JP2023541430A5 (enExample)
JP2024133475A5 (enExample)
JP2024133474A5 (enExample)
JP6353577B2 (ja) 組み合わせ組成物
BR0207024A (pt) Medicamento com ação inicial rápida para o tratamento de disfunção sexual
JPH0717501B2 (ja) 高めた無痛覚を与える製薬製品
JP2024534427A5 (enExample)
CN1856339A (zh) 肺动脉高血压症治疗的伊洛前列素联合疗法
JP2022550919A5 (enExample)
KR20200070246A (ko) 이중층 제약 정제 제제
JP2024520690A5 (enExample)
MX2024006270A (es) Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas.
MX2024010637A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
JP2023537921A5 (enExample)
AU2009215329B2 (en) Combination comprising paclitaxel for treating ovarian cancer
JP2024501919A5 (enExample)
JP2024531799A5 (enExample)
JP5837877B2 (ja) 静脈内投与イブプロフェンを用いた患者の治療
TWI341728B (en) Combinations comprising epothilones and anti-metabolites
JP2025509278A5 (enExample)
JP2022177119A5 (enExample)
JP2025148408A5 (enExample)
JP7369523B2 (ja) 中等度～重度のインフルエンザの処置
JP7758655B2 (ja) 組合せ